CRP and hematopoietic and lymphoid cell neoplasm: First, among blood and biochemical measurements, the hematologic cancer cohort displayed increased CRP and D-dimer concentrations and lower hematocrit and hemoglobin levels in patients that progressed to death (Severe-Death group) (Figures 2B, C).